NICE guideline: Safe prescribing and withdrawal management of prescribed drugs associated with dependence and withdrawal
The final scope and equality impact assessment for this NICE guideline have now been published, along with all the stakeholder comments that were received during consultation and our responses to these comments.
NICE identified ARMA as a stakeholder for this topic and ARMA is able to comment on the draft guideline when it is available. Please contact us should you have an interest in this topic and are a member.…
Read more of this article
Medical Devices Regulation from 2020
by Jenny Brodie, Senior Communications & Brand Officer, NASS
Guest blog by Dr Alison Giles, Associate Director for Healthy Ageing, Centre for Ageing Better and Public Health England; and Elaine Rashbrook, Consultant Specialist, Life Course, Public Health England.
October saw the launch of a new National Academy for Social Prescribing (NASP), to champion social prescribing and the work of local communities in connecting people for wellbeing. Its objectives include exploring new ways of sourcing statutory and non-statutory funding and brokering relationships between different sectors. Given the prevalence of MSK conditions, it is important that social prescribing has something to offer for MSK.
Bone and Joint Week in October helps get people thinking about one of the most widespread and pressing health issues of our times – musculoskeletal health and the role each person in improving it. This year ARMA’s member organisations, Public Health England, NHE England, NHS Confederation and many other organisations collaborated during the campaign using 
ARMA joins Public Health England and the Centre for Ageing Better to make England the best place to grow old, because musculoskeletal health is vital to healthy ageing.